)
AtriCure (ATRC) investor relations material
AtriCure Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved total revenue of $534.5 million in 2025, up 14.9% year-over-year, with Q4 revenue of $140.5 million, up 13.1% year-over-year, driven by pain management, open appendage management, and open ablation franchises.
Adjusted EBITDA reached $61.8 million for 2025, nearly doubling from 2024, with Q4 adjusted EBITDA of $19.9 million; net income turned positive in Q4 2025 at $1.8 million.
Growth fueled by new product launches including AtriClip PRO-Mini, cryoXT probe, cryoSPHERE MAX, AtriClip FLEX-Mini, and EnCompass clamp.
Maintained leadership in innovation and clinical evidence, with over 100,000 patients treated using cryoSPHERE probes since 2019.
Financial highlights
Q4 2025 revenue was $140.5 million, up 13.1% year-over-year; U.S. revenue grew 12.6% to $114.3 million, international revenue up 15.3% to $26.2 million.
Gross margin for 2025 was 75.0%, up 29 basis points from 2024, with Q4 gross profit at $105.3 million.
Adjusted EBITDA for 2025 was $61.8 million, up from $31.1 million in 2024; Q4 adjusted EBITDA was $19.9 million.
Net income for Q4 2025 was $1.8 million, compared to a $15.6 million loss in Q4 2024; EPS improved to $0.04.
Ended 2025 with $167.4 million in cash and investments, generating $45 million in cash for the year.
Outlook and guidance
2026 revenue guidance reaffirmed at $600–$610 million, representing 12–14% growth over 2025.
Adjusted EBITDA guidance for 2026 is $80–$82 million, with positive net income and adjusted EPS of $0.09–$0.15.
Pain management expected to lead growth in 2026, with open appendage management and open ablation also strong.
Anticipates continued pressure in minimally invasive ablation and MIS appendage management, but at a lower rate of decline.
Expects positive cash generation for full year 2026, despite a net cash burn in Q1 due to seasonal factors.
Next AtriCure earnings date
Next AtriCure earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)